Impact of risk minimisation measures on the use of strontium ranelate: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance

Documents similaires

• Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU‐ADR Alliance
  par: Berencsi, K, et autres
  Publié: (2018)
• Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: a multi-database study in our European countries by the EU-ADR Alliance
  par: Ali, M, et autres
  Publié: (2017)
• Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi‐database study in 5 EU countries by the EU‐ADR Alliance
  par: Ali, M, et autres
  Publié: (2018)
• A multi-database, multinational validation study of cardiovascular death, venous thromboembolic events and gastrointestinal diseases in the EU-ADR Alliance
  par: Ying, H, et autres
  Publié: (2018)
• The impact of risk minimisation measures on the incidence and prevalence of use of strontium ranelate at the population level: preliminary results of a multi-national cohort study including 5 European countries
  par: Berencsi, K, et autres
  Publié: (2016)